| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.12B | 990.40M | 599.00M | 989.50M | 672.40M | 256.30M |
| Gross Profit | 1.11B | 951.40M | 579.10M | 934.70M | 656.80M | 246.00M |
| EBITDA | 756.80M | 548.30M | 0.00 | 637.10M | 585.30M | 124.50M |
| Net Income | 596.00M | 451.20M | 280.60M | 526.80M | 457.10M | 108.90M |
Balance Sheet | ||||||
| Total Assets | 9.95B | 9.34B | 9.05B | 8.87B | 7.46B | 7.02B |
| Cash, Cash Equivalents and Short-Term Investments | 1.25B | 604.80M | 550.00M | 761.50M | 296.90M | 947.90M |
| Total Debt | 6.97B | 6.11B | 6.11B | 6.02B | 5.20B | 1.93B |
| Total Liabilities | 7.34B | 6.85B | 7.01B | 6.87B | 5.84B | 5.71B |
| Stockholders Equity | 2.61B | 2.49B | 2.02B | 1.97B | 1.62B | 1.31B |
Cash Flow | ||||||
| Free Cash Flow | 33.40M | 129.50M | 280.40M | 235.60M | 100.20M | 290.80M |
| Operating Cash Flow | 33.80M | 136.10M | 291.60M | 243.40M | 111.00M | 300.90M |
| Investing Cash Flow | 814.50M | 276.10M | 130.80M | 45.50M | 64.70M | -74.00M |
| Financing Cash Flow | -425.70M | -524.60M | -476.70M | 111.30M | -653.30M | 471.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £4.19B | 6.07 | 7.96% | 7.21% | -1.72% | 63.64% | |
76 Outperform | £9.02B | 4.03 | 12.35% | 5.37% | 12.45% | 28.89% | |
73 Outperform | £21.18B | 3.09 | 17.91% | 2.44% | -74.69% | 2.97% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £5.13B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
54 Neutral | £2.31B | 110.86 | 4.25% | 2.85% | 47.14% | -37.72% | |
52 Neutral | £7.36B | 28.90 | 9.49% | 7.09% | 52.52% | ― |